Position in VCYT
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$566,744
+$286,517 QoQ
Shares Held
9,650
+10.9% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#207
of 367 holders
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCYT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Catalyst Funds Management Pty Ltd holds $17,014,989 across 10 Diagnostics & Research names. VCYT ranks #5 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
73,300 | $10,997,199 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
4,360 | $2,185,929 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
1,821 | $958,647 | |
| 4 | ILMN |
Illumina, Inc.
|
4,200 | $738,486 | |
| 5 | VCYT |
Veracyte, Inc.
This page
|
9,650 | $566,744 | |
| 6 | WAT |
Waters Corp /De/
|
1,360 | $510,054 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
2,251 | $434,938 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
950 | $215,450 |
All Filings in VCYT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $566,744 | 9,650 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $280,227 | 8,700 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $231,550 | 5,500 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $226,578 | 6,600 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $332,469 | 12,300 | Shares | Sole | 2025-08-12 | |
| 2024-06-30 | $43,340 | 2,000 | Shares | Sole | 2024-12-18 | |
| 2024-03-31 | $15,512 | 700 | Shares | Sole | 2024-12-05 | |
| No filing history on record for this holder in this stock. | ||||||